Development and Computational Analysis of Polyherbal Chewable Lozenges for Effective Management of Mouth and Throat Infections

This study aimed to develop and evaluate polyherbal chewable lozenges for the treatment of mouth and throat infections, integrating traditional herbal knowledge with modern pharmaceutical and computational techniques. The lozenges were formulated using Karpuravalli (Coleus amboinicus), Ginger (Zingiber officinale), Cardamom (Elettaria cardamomum), and Clove Oil (Syzygium aromaticum), and their quality, efficacy, and therapeutic potential were rigorously assessed. Quality control tests, including weight variation, friability, moisture content, and dissolution, confirmed the lozenges' compliance with pharmaceutical standards. The dissolution profile demonstrated a cumulative drug release of 91.26% within 25 minutes, indicating efficient bioavailability. Antimicrobial activity tests revealed significant efficacy against Staphylococcus aureus (15 mm inhibition zone) and Escherichia coli (25 mm inhibition zone), with E. coli showing greater susceptibility. Molecular docking studies identified Rosmarinic Acid and Beta-Sitosterol as key bioactive compounds, exhibiting strong binding affinities with bacterial enzymes such as Dihydrofolate Reductase (DHFR) and UDP-N-Acetylglucosamine Enolpyruvyl Transferase, suggesting potential inhibitory mechanisms. Pharmacokinetic and drug-likeness evaluations using Lipinski’s Rule of Five and Swiss ADME highlighted favorable properties for compounds like Carvacrol and Gingerol, while bioactivity scores indicated diverse interaction potentials. The study underscores the lozenges' adherence to quality standards and their potential as effective antimicrobial agents. However, further optimization of formulation strategies, mechanistic studies, and clinical trials are necessary to validate their therapeutic efficacy and safety. This research contributes to the growing body of evidence supporting the use of polyherbal formulations in modern therapeutics, offering a natural and scientifically validated alternative for managing oral and throat infections.

Authors

Publication Details

Journal
Palestinian medical and pharmaceutical journal/Palestinian medical & pharmaceutical journal
Published
2025-05-01
DOI
https://doi.org/10.59049/2790-0231.11.3.2509
Primary Topic
Infant Health and Development
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and Computational Analysis of Polyherbal Chewable Lozenges for Effective Management of Mouth and Throat Infections

Zaid Khan, Chitturi Ramya, B A Vishwanath, Deepthi Swapna PR
Palestinian medical and pharmaceutical journal/Palestinian medical & pharmaceutical journal
Infant Health and Development
article

Development and Computational Analysis of Polyherbal Chewable Lozenges for Effective Management of Mouth and Throat Infections

Zaid Khan, Chitturi Ramya, B A Vishwanath, Deepthi Swapna PR
article en

Abstract

This study aimed to develop and evaluate polyherbal chewable lozenges for the treatment of mouth and throat infections, integrating traditional herbal knowledge with modern pharmaceutical and computational techniques. The lozenges were formulated using Karpuravalli (Coleus amboinicus), Ginger (Zingiber officinale), Cardamom (Elettaria cardamomum), and Clove Oil (Syzygium aromaticum), and their quality, efficacy, and therapeutic potential were rigorously assessed. Quality control tests, including weight variation, friability, moisture content, and dissolution, confirmed the lozenges' compliance with pharmaceutical standards. The dissolution profile demonstrated a cumulative drug release of 91.26% within 25 minutes, indicating efficient bioavailability. Antimicrobial activity tests revealed significant efficacy against Staphylococcus aureus (15 mm inhibition zone) and Escherichia coli (25 mm inhibition zone), with E. coli showing greater susceptibility. Molecular docking studies identified Rosmarinic Acid and Beta-Sitosterol as key bioactive compounds, exhibiting strong binding affinities with bacterial enzymes such as Dihydrofolate Reductase (DHFR) and UDP-N-Acetylglucosamine Enolpyruvyl Transferase, suggesting potential inhibitory mechanisms. Pharmacokinetic and drug-likeness evaluations using Lipinski’s Rule of Five and Swiss ADME highlighted favorable properties for compounds like Carvacrol and Gingerol, while bioactivity scores indicated diverse interaction potentials. The study underscores the lozenges' adherence to quality standards and their potential as effective antimicrobial agents. However, further optimization of formulation strategies, mechanistic studies, and clinical trials are necessary to validate their therapeutic efficacy and safety. This research contributes to the growing body of evidence supporting the use of polyherbal formulations in modern therapeutics, offering a natural and scientifically validated alternative for managing oral and throat infections.

Palestinian medical and pharmaceutical journal/Palestinian medical & pharmaceutical journalVol. 11(2)
Openalex Percentile: Top 59%
Infant Health and Development
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development and Computational Analysis of Polyherbal Chewable Lozenges for Effective Management of Mouth and Throat Infections — Zaid Khan, Chitturi Ramya, et al. · Palestinian medical and pharmaceutical journal/Palestinian medical & pharmaceutical journal (2025) | TGRS Research Map | TGRS